BioClinica Investor Wants $123M PE Takeover Put On Ice

A BioClinica Inc. investor launched a putative class action Friday aimed at halting its acquisition by private equity firm JLL Partners Inc., claiming the announced $123 million buyout undervalues the promising...

Already a subscriber? Click here to view full article